Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Bapcor (BAP.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-04-01	6.22	8.10	Buy
2022-05-04	6.25	7.90	Buy
2022-07-28	6.55	7.60	Buy
2022-08-17	6.85	7.70	Buy
2022-11-23	6.73	7.60	Buy
2023-02-17	6.33	7.50	Buy
2023-06-21	6.04	7.20	Buy
2023-08-17	6.59	7.20	Neutral
2024-01-29	5.58	6.10	Neutral
2024-02-23	5.99	6.00	Neutral
2024-05-02	4.40	4.70	Neutral
2024-06-12	5.02	-	No Rating

Disclosures

UBS Securities Australia Limited is acting as financial advisor to Bain Capital on its acquisition of Bapcor and will receive a fee for acting in this capacity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.